1. Home
  2. TNL vs TARS Comparison

TNL vs TARS Comparison

Compare TNL & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travel   Leisure Co.

TNL

Travel Leisure Co.

N/A

Current Price

$62.45

Market Cap

3.9B

ML Signal

N/A

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

N/A

Current Price

$75.86

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TNL
TARS
Founded
1990
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.6B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
TNL
TARS
Price
$62.45
$75.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
10
Target Price
$91.17
★ $99.50
AVG Volume (30 Days)
554.5K
★ 615.8K
Earning Date
10-27-2026
11-03-2026
Dividend Yield
★ 3.88%
N/A
EPS Growth
N/A
★ 48.21
EPS
★ 2.94
N/A
Revenue
★ $4,021,000,000.00
$451,360,000.00
Revenue This Year
$4.03
$59.75
Revenue Next Year
$4.87
$28.60
P/E Ratio
$21.70
★ N/A
Revenue Growth
4.06
★ 146.71
52 Week Low
$58.09
$53.89
52 Week High
$81.00
$91.53

Technical Indicators

Market Signals
Indicator
TNL
TARS
Relative Strength Index (RSI) 27.83 56.70
Support Level N/A $60.95
Resistance Level $73.66 $79.10
Average True Range (ATR) 1.72 2.35
MACD 0.08 -0.51
Stochastic Oscillator 0.00 80.38

Price Performance

Historical Comparison
TNL
TARS

About TNL Travel Leisure Co.

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including two vacation exchange brands, Vacation Ownership and Travel and Membership The majority of the revenue is earned from the United States.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: